Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27.

PMID:
29076399
2.

Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects.

Lathuilière A, Valdés P, Papin S, Cacquevel M, Maclachlan C, Knott GW, Muhs A, Paganetti P, Schneider BL.

Sci Rep. 2017 Oct 19;7(1):13556. doi: 10.1038/s41598-017-13786-2.

3.

A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.

Trzeciakiewicz H, Tseng JH, Wander CM, Madden V, Tripathy A, Yuan CX, Cohen TJ.

Sci Rep. 2017 Mar 13;7:44102. doi: 10.1038/srep44102.

4.

Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.

Kimura T, Hosokawa T, Taoka M, Tsutsumi K, Ando K, Ishiguro K, Hosokawa M, Hasegawa M, Hisanaga S.

Sci Rep. 2016 Sep 19;6:33479. doi: 10.1038/srep33479.

5.

Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition.

Rzechorzek NM, Connick P, Livesey MR, Borooah S, Patani R, Burr K, Story D, Wyllie DJA, Hardingham GE, Chandran S.

EBioMedicine. 2015 Dec 12;3:141-154. doi: 10.1016/j.ebiom.2015.12.010. eCollection 2016 Jan.

6.

RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.

Wong H, Levenga J, Cain P, Rothermel B, Klann E, Hoeffer C.

Acta Neuropathol. 2015 Dec;130(6):829-43. doi: 10.1007/s00401-015-1499-8. Epub 2015 Oct 24.

7.

Hippocampal plasticity during the progression of Alzheimer's disease.

Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, Ginsberg SD, Ikonomovic MD, Scheff SW, Binder LI.

Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12. Review.

8.

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.

Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, Louneva N, Lee VM, Kim SF, Trojanowski JQ, Arnold SE.

Acta Neuropathol. 2014 Nov;128(5):679-89. doi: 10.1007/s00401-014-1328-5. Epub 2014 Aug 9.

9.

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro S, Eckermann K, Outeiro TF.

Front Mol Neurosci. 2014 May 13;7:42. doi: 10.3389/fnmol.2014.00042. eCollection 2014. Review.

10.

Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice.

Tao G, Zhang J, Zhang L, Dong Y, Yu B, Crosby G, Culley DJ, Zhang Y, Xie Z.

Anesthesiology. 2014 Sep;121(3):510-27. doi: 10.1097/ALN.0000000000000278.

11.

Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.

Ozcelik S, Fraser G, Castets P, Schaeffer V, Skachokova Z, Breu K, Clavaguera F, Sinnreich M, Kappos L, Goedert M, Tolnay M, Winkler DT.

PLoS One. 2013 May 7;8(5):e62459. doi: 10.1371/journal.pone.0062459. Print 2013.

12.

Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.

Lim J, Balastik M, Lee TH, Nakamura K, Liou YC, Sun A, Finn G, Pastorino L, Lee VM, Lu KP.

J Clin Invest. 2008 May;118(5):1877-89. doi: 10.1172/JCI34308.

13.

Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marié I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, Duff K.

Neuron. 2008 Mar 13;57(5):680-90. doi: 10.1016/j.neuron.2008.02.024.

14.

Lithium blocks ethanol-induced modulation of protein kinases in the developing brain.

Chakraborty G, Saito M, Mao RF, Wang R, Vadasz C, Saito M.

Biochem Biophys Res Commun. 2008 Mar 14;367(3):597-602. doi: 10.1016/j.bbrc.2008.01.004. Epub 2008 Jan 9.

15.

Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.

Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, Leist M, Lotharius J.

Br J Pharmacol. 2007 Nov;152(6):959-79. Epub 2007 Oct 1.

16.
17.

Nitration of tau protein is linked to neurodegeneration in tauopathies.

Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C, Richter-Landsberg C, Lee VM, Trojanowski JQ.

Am J Pathol. 2003 Sep;163(3):1021-31. Erratum in: Am J Pathol. 2003 Dec;163(6):2645.

18.
19.

Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin.

Mistry SJ, Li HC, Atweh GF.

Biochem J. 1998 Aug 15;334 ( Pt 1):23-9.

Supplemental Content

Support Center